Pharmacovigilance in Brazil: safety of budesonide-formoterol

R. Miranda (Guarulhos (SP), Brazil), A. Vattimo (Guarulhos (SP), Brazil), J. Fonseca (Guarulhos (SP), Brazil), M. Ramos (Guarulhos (SP), Brazil), A. Oliveira (Guarulhos (SP), Brazil), K. Barbosa (Guarulhos (SP), Brazil), S. Zung (Guarulhos (SP), Brazil)

Source: International Congress 2022 – Obstructive lung diseases: trends, diagnosis and management

Session: Obstructive lung diseases: trends, diagnosis and management
Session type: Thematic Poster
Number: 3912

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Miranda (Guarulhos (SP), Brazil), A. Vattimo (Guarulhos (SP), Brazil), J. Fonseca (Guarulhos (SP), Brazil), M. Ramos (Guarulhos (SP), Brazil), A. Oliveira (Guarulhos (SP), Brazil), K. Barbosa (Guarulhos (SP), Brazil), S. Zung (Guarulhos (SP), Brazil). Pharmacovigilance in Brazil: safety of budesonide-formoterol. 3912

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.